China Pharma Holdings, Inc.
CPHIAMEXHealthcare● Active
$0.72
$-0.11(-12.90%)
Market Cap$2275625
P/E Ratio—
52W High$2.05
52W Low$0.38
China Pharma Holdings, Inc. (CPHI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CPHI · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.14M | $4.53M | $7.01M | $8.10M | $9.64M |
| Cost of Revenue | $4.28M | $6.51M | $7.29M | $8.60M | $9.29M |
| Gross Profit | ($0.13M) | ($1.99M) | ($0.28M) | ($0.49M) | $0.35M |
| Gross Margin %(computed) | -3.18% | -43.84% | -4.01% | -6.09% | 3.62% |
| Operating Expenses | |||||
| R&D Expenses | $0.28M | $0.28M | $0.24M | $0.19M | $0.32M |
| G&A Expenses | $2.45M | $1.78M | $1.47M | $1.89M | $1.65M |
| Total Operating Expenses | $2.96M | $2.60M | $2.47M | $3.06M | $3.21M |
| Operating Income | ($3.09M) | ($4.59M) | ($2.75M) | ($3.55M) | ($2.86M) |
| Operating Margin %(computed) | -74.53% | -101.32% | -39.25% | -43.79% | -29.67% |
| Interest Income | $0.00M | $0.01M | $0.01M | $0.01M | $0.00M |
| Interest Expense | $0.10M | $0.15M | $0.33M | $0.43M | $0.54M |
| Income Before Tax | ($3.19M) | ($4.74M) | ($3.08M) | ($3.97M) | ($3.40M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($3.19M) | ($4.74M) | ($3.08M) | ($3.97M) | ($3.40M) |
| Net Margin %(computed) | -76.91% | -104.58% | -43.91% | -49.02% | -35.26% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.74 | $-0.27 | $-0.29 | $-1.94 | $-0.85 |
| Wtd Avg Shares | 4.29M | 17.46M | 10.60M | 5.26M | 4.61M |
| EBITDA | ($1.51M) | ($1.96M) | $0.01M | ($0.84M) | $0.23M |
| EBITDA Margin %(computed) | -36.35% | -43.37% | 0.12% | -10.34% | 2.39% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more China Pharma Holdings, Inc. data
About China Pharma Holdings, Inc. (CPHI) Income Statement
China Pharma Holdings, Inc. (CPHI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CPHI reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -3.18%), and net income of ($0.00B) — a net profit margin of -76.91%.
Frequently asked questions
CPHI · 4 questionsChina Pharma Holdings, Inc. (CPHI) reported revenue of $0.00B for 2025, down 8.5% year-over-year.
CPHI revenueCPHI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08